325 related articles for article (PubMed ID: 35459560)
1. ADAR1 and its implications in cancer development and treatment.
Baker AR; Slack FJ
Trends Genet; 2022 Aug; 38(8):821-830. PubMed ID: 35459560
[TBL] [Abstract][Full Text] [Related]
2. An RNA editing/dsRNA binding-independent gene regulatory mechanism of ADARs and its clinical implication in cancer.
Qi L; Song Y; Chan THM; Yang H; Lin CH; Tay DJT; Hong H; Tang SJ; Tan KT; Huang XX; Lin JS; Ng VHE; Maury JJP; Tenen DG; Chen L
Nucleic Acids Res; 2017 Oct; 45(18):10436-10451. PubMed ID: 28985428
[TBL] [Abstract][Full Text] [Related]
3. To protect and modify double-stranded RNA - the critical roles of ADARs in development, immunity and oncogenesis.
Erdmann EA; Mahapatra A; Mukherjee P; Yang B; Hundley HA
Crit Rev Biochem Mol Biol; 2021 Feb; 56(1):54-87. PubMed ID: 33356612
[TBL] [Abstract][Full Text] [Related]
4. RNA editing and immune control: from mechanism to therapy.
Hu SB; Li JB
Curr Opin Genet Dev; 2024 Jun; 86():102195. PubMed ID: 38643591
[TBL] [Abstract][Full Text] [Related]
5. ADARs and editing: The role of A-to-I RNA modification in cancer progression.
Fritzell K; Xu LD; Lagergren J; Öhman M
Semin Cell Dev Biol; 2018 Jul; 79():123-130. PubMed ID: 29146145
[TBL] [Abstract][Full Text] [Related]
6. Transcriptome Profiling of ADAR1 Targets in Triple-Negative Breast Cancer Cells Reveals Mechanisms for Regulating Growth and Invasion.
Baker AR; Miliotis C; Ramírez-Moya J; Marc T; Vlachos IS; Santisteban P; Slack FJ
Mol Cancer Res; 2022 Jun; 20(6):960-971. PubMed ID: 35247916
[TBL] [Abstract][Full Text] [Related]
7. Adenosine Deaminase Acting on RNA 1 Associates with Orf Virus OV20.0 and Enhances Viral Replication.
Liao GR; Tseng YY; Tseng CY; Lin FY; Yamada Y; Liu HP; Kuan CY; Hsu WL
J Virol; 2019 Apr; 93(7):. PubMed ID: 30651363
[TBL] [Abstract][Full Text] [Related]
8. The role of RNA editing enzyme ADAR1 in human disease.
Song B; Shiromoto Y; Minakuchi M; Nishikura K
Wiley Interdiscip Rev RNA; 2022 Jan; 13(1):e1665. PubMed ID: 34105255
[TBL] [Abstract][Full Text] [Related]
9. Adenosine-to-inosine RNA editing by ADAR1 is essential for normal murine erythropoiesis.
Liddicoat BJ; Hartner JC; Piskol R; Ramaswami G; Chalk AM; Kingsley PD; Sankaran VG; Wall M; Purton LE; Seeburg PH; Palis J; Orkin SH; Lu J; Li JB; Walkley CR
Exp Hematol; 2016 Oct; 44(10):947-63. PubMed ID: 27373493
[TBL] [Abstract][Full Text] [Related]
10. Adenosine Deaminases Acting on RNA (ADARs) and Viral Infections.
Pfaller CK; George CX; Samuel CE
Annu Rev Virol; 2021 Sep; 8(1):239-264. PubMed ID: 33882257
[TBL] [Abstract][Full Text] [Related]
11. ADAR1-mediated RNA editing is a novel oncogenic process in thyroid cancer and regulates miR-200 activity.
Ramírez-Moya J; Baker AR; Slack FJ; Santisteban P
Oncogene; 2020 Apr; 39(18):3738-3753. PubMed ID: 32157211
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms and implications of ADAR-mediated RNA editing in cancer.
Wang C; Zou J; Ma X; Wang E; Peng G
Cancer Lett; 2017 Dec; 411():27-34. PubMed ID: 28974449
[TBL] [Abstract][Full Text] [Related]
13. Chimeric double-stranded RNA-specific adenosine deaminase ADAR1 proteins reveal functional selectivity of double-stranded RNA-binding domains from ADAR1 and protein kinase PKR.
Liu Y; Lei M; Samuel CE
Proc Natl Acad Sci U S A; 2000 Nov; 97(23):12541-6. PubMed ID: 11070079
[TBL] [Abstract][Full Text] [Related]
14. Adenosine Deaminases Acting on RNA Downregulate the Expression of Constitutive Androstane Receptor in the Human Liver-Derived Cells by Attenuating Splicing.
Nakano M; Fukami T; Nakajima M
J Pharmacol Exp Ther; 2019 Sep; 370(3):408-415. PubMed ID: 31270214
[TBL] [Abstract][Full Text] [Related]
15. An RNA editor, adenosine deaminase acting on double-stranded RNA (ADAR1).
George CX; John L; Samuel CE
J Interferon Cytokine Res; 2014 Jun; 34(6):437-46. PubMed ID: 24905200
[TBL] [Abstract][Full Text] [Related]
16. In cancer, A-to-I RNA editing can be the driver, the passenger, or the mechanic.
Ganem NS; Ben-Asher N; Lamm AT
Drug Resist Updat; 2017 May; 32():16-22. PubMed ID: 29145975
[TBL] [Abstract][Full Text] [Related]
17. Base-pairing probability in the microRNA stem region affects the binding and editing specificity of human A-to-I editing enzymes ADAR1-p110 and ADAR2.
Ishiguro S; Galipon J; Ishii R; Suzuki Y; Kondo S; Okada-Hatakeyama M; Tomita M; Ui-Tei K
RNA Biol; 2018; 15(7):976-989. PubMed ID: 29950133
[TBL] [Abstract][Full Text] [Related]
18. Restricting retrotransposons: ADAR1 is another guardian of the human genome.
Orecchini E; Frassinelli L; Michienzi A
RNA Biol; 2017 Nov; 14(11):1485-1491. PubMed ID: 28640667
[TBL] [Abstract][Full Text] [Related]
19. irCLASH reveals RNA substrates recognized by human ADARs.
Song Y; Yang W; Fu Q; Wu L; Zhao X; Zhang Y; Zhang R
Nat Struct Mol Biol; 2020 Apr; 27(4):351-362. PubMed ID: 32203492
[TBL] [Abstract][Full Text] [Related]
20. Adenosine-to-inosine RNA editing mediated by ADARs in esophageal squamous cell carcinoma.
Qin YR; Qiao JJ; Chan TH; Zhu YH; Li FF; Liu H; Fei J; Li Y; Guan XY; Chen L
Cancer Res; 2014 Feb; 74(3):840-51. PubMed ID: 24302582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
